Published in Acta Endocrinol (Copenh) on November 01, 1980
Study of fluxes at low concentrations of L-tri-iodothyronine with rat liver cells and their plasma-membrane vesicles. Evidence for the accumulation of the hormone against a gradient. Biochem J (1981) 0.83
Role of sodium in thyroid hormone uptake by rat skeletal muscle. J Clin Invest (1987) 0.80
Evidence that the uptake of tri-iodo-L-thyronine by human erythrocytes is carrier-mediated but not energy-dependent. Biochem J (1982) 0.78
Thyroid hormone concentrative uptake in rat erythrocytes. Involvement of the tryptophan transport system T in countertransport of tri-iodothyronine and aromatic amino acids. Biochem J (1992) 0.76
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79
The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol (1999) 3.50
Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64
Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes (2001) 2.21
On the conformational stability of globular proteins. The effects of various electrolytes and nonelectrolytes on the thermal ribonuclease transition. J Biol Chem (1965) 2.17
Electrostatic enhancement of diffusion-controlled protein-protein association: comparison of theory and experiment on barnase and barstar. J Mol Biol (1998) 2.13
Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97
Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care (1990) 1.90
Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology (1984) 1.79
Cortisol in saliva--reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem (1995) 1.73
Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70
Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. J Cell Biol (1985) 1.68
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene (1999) 1.66
Surface markers and prognostic factors in acute lymphoblastic leukemia. N Engl J Med (1976) 1.64
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res (1999) 1.63
Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis (2010) 1.62
Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes (2000) 1.62
Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol (2008) 1.61
Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Proc Natl Acad Sci U S A (1982) 1.57
Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport. J Biol Chem (1972) 1.56
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes (1999) 1.56
Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat. J Biol Chem (1974) 1.55
DNA synthesis in human fibroblasts: stimulation by insulin and by nonsuppressible insulin-like activity (NSILA-S). J Clin Endocrinol Metab (1974) 1.53
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51
Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol (2012) 1.48
Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man. Recent Prog Horm Res (1975) 1.47
Bile secretory apparatus: evidence for a vesicular transport mechanism for proteins in the rat, using horseradish peroxidase and [125I]insulin. Gastroenterology (1980) 1.42
The insulin-pancreatic acinar axis. Diabetes (1985) 1.42
Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem (1980) 1.41
Binding of insulin to isolated nuclei. Proc Natl Acad Sci U S A (1976) 1.34
Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J Biol Chem (1990) 1.31
Insulin receptor expression and function in human breast cancer cell lines. Cancer Res (1992) 1.31
Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J (2001) 1.27
Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist. Biochem Biophys Res Commun (1983) 1.27
Entry of insulin into human cultured lymphocytes: electron microscope autoradiographic analysis. Science (1978) 1.25
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem (1988) 1.23
Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance. Biochem Biophys Res Commun (1973) 1.23
Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia (2007) 1.21
Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem Biophys Res Commun (1994) 1.19
Dynamic aspects of native DNA structure: kinetics of the formaldehyde reaction with calf thymus DNA. J Mol Biol (1971) 1.19
Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology (1978) 1.18
Relation of arterial stiffness with gestational age and birth weight. Arch Dis Child (2004) 1.17
Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci U S A (1987) 1.15
Conventional radiation therapy in acromegaly. A review and reassessment. Arch Intern Med (1971) 1.14
Cholecystokinin receptors in the brain: characterization and distribution. Science (1980) 1.13
Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Biochem Biophys Res Commun (1988) 1.13
Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther (2000) 1.11
High affinity thyroid hormone binding sites on purified rat liver plasma membranes. Biochem Biophys Res Commun (1977) 1.09
Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol (2007) 1.09
Glucagon receptors in -cells. Binding of 125 I-glucagon and activation of adenylate cyclase. J Biol Chem (1972) 1.09
Radioimmunoassay of human plasminogen and plasmin. J Lab Clin Med (1969) 1.09
Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians (1997) 1.08
Congenital dyserythropoietic anemia type II: ultrastructural and radioautographic studies of blood and bone marrow. Blood (1972) 1.08
Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res (1985) 1.06
Assembly of insulin/insulin-like growth factor-1 hybrid receptors in vitro. J Biol Chem (1989) 1.05
Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes (1985) 1.04
Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem (1987) 1.04
Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia (1997) 1.04
Growth hormone dynamics in acromegaly. J Clin Endocrinol Metab (1970) 1.03
Proximal-row carpectomy. An end-result study of twenty-two cases. J Bone Joint Surg Am (1969) 1.02
Emergency management of dental trauma: knowledge of Hong Kong primary and secondary school teachers. Hong Kong Med J (2012) 1.02
Does insulin need a second messenger? Diabetes (1977) 1.02
ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Mol Carcinog (1997) 1.02
The significance of LMO2 expression in the progression of prostate cancer. J Pathol (2007) 1.02
Synthesis of inducible tyrosine aminotransferase in a cell-free extract from cultured hepatoma cells. Proc Natl Acad Sci U S A (1972) 1.02
Design of fast enzymes by optimizing interaction potential in active site. Proc Natl Acad Sci U S A (1997) 1.01
Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem (1989) 1.01
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm (1979) 1.00
Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol (1991) 1.00
An evidence base for International Health Regulations: quantitative measurement of the impacts of epidemic disease on international trade. Rev Sci Tech (2005) 1.00
Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody. J Clin Invest (1984) 1.00
Insulin receptors in breast cancer. Ann N Y Acad Sci (1996) 1.00
Degradation of insulin by isolated mouse pancreatic acini. Evidence for cell surface protease activity. Diabetes (1984) 1.00
Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative. Am J Physiol (1980) 1.00
Regulation of the insulin receptor by a monoclonal anti-receptor antibody. Evidence that receptor down regulation can be independent of insulin action. J Biol Chem (1983) 0.99
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia (2004) 0.99
Insulin regulation of protein phosphorylation in isolated rat liver nuclear envelopes: potential relationship to mRNA metabolism. Proc Natl Acad Sci U S A (1983) 0.98
Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62, and GTPase-activating protein. J Biol Chem (1994) 0.98
Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Am J Physiol (1982) 0.97
The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem (1989) 0.97
Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J Clin Invest (1991) 0.97
Insulin receptors in isolated mouse pancreatic acini. Biochem Biophys Res Commun (1978) 0.97
The somatostatin receptor on isolated pancreatic acinar cell plasma membranes. Identification of subunit structure and direct regulation by cholecystokinin. J Biol Chem (1984) 0.96
Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood (2000) 0.96
Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes (1991) 0.96
Interactions of a monoclonal antibody to the insulin receptor with receptors for insulin-like growth factors. Endocrinology (1983) 0.95
Preparation of biologically active 125I-TSH. Endocrinology (1974) 0.95